Earnings summaries and quarterly performance for RadNet.
Executive leadership at RadNet.
Howard Berger
Detailed
President and Chief Executive Officer
CEO
CW
Cornelis Wesdorp
Detailed
President and Chief Executive Officer - Digital Health
DK
David Katz
Detailed
Executive Vice President, Chief Legal Officer and Corporate Secretary
GS
Gregory Sorensen
Detailed
Executive Vice President, Chief Science Officer
MS
Mark Stolper
Detailed
Executive Vice President and Chief Financial Officer
MM
Michael Murdock
Detailed
Executive Vice President, Mergers and Acquisitions
MP
Mital Patel
Detailed
Executive Vice President of Financial Planning and Analysis and Chief Administrative Officer
NH
Norman Hames
Detailed
President and Chief Operating Officer - Western Operations
RJ
Ranjan Jayanathan
Detailed
Executive Vice President, Chief Information Officer
SF
Stephen Forthuber
Detailed
President and Chief Operating Officer - Eastern Operations
Board of directors at RadNet.
Research analysts who have asked questions during RadNet earnings calls.
Brian Tanquilut
Jefferies
9 questions for RDNT
Also covers: ACHC, ADUS, AHCO +31 more
Andrew Mok
Barclays
8 questions for RDNT
Also covers: ACHC, ADUS, AGL +21 more
DM
David Macdonald
Truist Securities
7 questions for RDNT
Also covers: AVAH, ENSG, GRDN +3 more
JR
John Ransom
Raymond James
6 questions for RDNT
Also covers: ACHC, ADUS, ALHC +11 more
YZ
Yuan Zhi
B. Riley Financial, Inc.
6 questions for RDNT
Also covers: HYPR, LNTH, MIR +5 more
Jim Sidoti
Sidoti & Company, LLC
5 questions for RDNT
Also covers: ANIK, GAIA, GOCO +6 more
LS
Larry Solow
CJS Securities
4 questions for RDNT
Also covers: ARCB, BTSG, CDRE +16 more
James Sidoti
Sidoti & Company
3 questions for RDNT
Also covers: ANIK, ASRT, GAIA +10 more
LS
Lawrence Solow
CJS Securities, Inc.
3 questions for RDNT
Also covers: BTSG, CDRE, CLH +13 more
MG
Matthew Gillmor
KeyCorp
2 questions for RDNT
Also covers: ACHC, ADUS, ALHC +12 more
Brandon Carney
B. Riley
1 question for RDNT
Also covers: CATX, HYPR, VREX
Evan Kane
Barclays
1 question for RDNT
GM
Grayson McAllister
Truist Securities
1 question for RDNT
Also covers: AVAH, GRDN
Recent press releases and 8-K filings for RDNT.
RadNet Reports Strong 2025 Performance, Provides Robust 2026 Guidance, and Details Strategic Acquisitions
RDNT
Guidance Update
Revenue Acceleration/Inflection
M&A
- RadNet reported strong 2025 performance with revenue up over 14.8% and substantial EBITDA growth, and provided 2026 guidance for revenue growth of 17%-19% and EBITDA growth of 18%-22%.
- The company completed its largest acquisition, Gleamer, to expand its AI offerings in X-ray, expecting $7 million in revenue synergies and profitability within 12 months.
- RadNet's digital health segment is projected to grow over 50% in 2026, with a strategic goal to reduce RadNet's customer concentration from 45% of digital health revenue in 2025 to below 20% by the end of 2028.
- Despite a challenging labor market, RadNet aims to improve company-wide EBITDA margins by 100-150 basis points by the end of 2028 through efficiency initiatives like TechLive and See-Mode.
- The company continues to secure strong rate increases from capitated and commercial payers, leveraging the lower cost of outpatient imaging compared to hospitals.
5 hours ago
RadNet Discusses 2026 Outlook and Strategic Initiatives at Barclays Conference
RDNT
Guidance Update
M&A
New Projects/Investments
- RadNet reported a strong 2025 with revenue up over 14.8% and substantial EBITDA growth, and provided 2026 guidance for revenue growth between 17%-19% and EBITDA growth between 18%-22%, implying margin improvement.
- The company projects over 50% growth in its digital health segment for 2026, fueled by organic expansion and strategic acquisitions, notably Gleamer, which enhances AI capabilities in X-ray and has achieved over 90% compound annual growth rate (CAGR) in annual recurring revenue (ARR) since 2022.
- To counter a challenging labor market, RadNet is deploying technologies such as TechLive for remote MRI scanning and C-mode for automated thyroid ultrasounds, aiming to increase efficiency, reduce exam room closure hours, and decrease exam times by 30%-50%.
6 hours ago
RadNet Discusses Strong 2025 Performance, 2026 Outlook, and Strategic AI Acquisition
RDNT
Guidance Update
M&A
New Projects/Investments
- RadNet reported a strong 2025, with revenue up over 14.8% and substantial EBITDA growth, and provided 2026 guidance projecting revenue growth of 17%-19% and EBITDA growth of 18%-22%.
- The company recently completed its largest acquisition, Gleamer, to enhance its AI offerings, particularly in X-ray, with Gleamer's annual recurring revenue (ARR) growing over 90% compound annual growth rate since 2022.
- RadNet's digital health segment is projected to grow over 50% in 2026, with the reliance on RadNet as a customer for this segment expected to decrease from 45% of revenue in 2025 to 33% in 2026, and below 20% by the end of 2028.
- Despite a challenging labor market, RadNet aims to increase company-wide EBITDA margins by 100-150 basis points by the end of 2028 through efficiency initiatives like TechLive and C-mode.
6 hours ago
RadNet acquires Gleamer
RDNT
M&A
New Projects/Investments
Revenue Acceleration/Inflection
- RadNet's digital health arm, DeepHealth, has acquired Gleamer, a Paris-based artificial intelligence company, for an all-cash transaction of up to EUR 230 million ($270 million).
- The acquisition expands the combined entity's portfolio to 26 FDA cleared and 22 CE marked devices and accelerates commercial reach to over 2,700 customer contracts across 50 countries.
- Gleamer has demonstrated 90% annual recurring revenue (ARR) growth over the last four years and is expected to deliver $30 million ARR in 2026.
- The combined DeepHealth and Gleamer entity is guided to achieve $135 million-$145 million in revenue for 2026, with $120 million-$140 million in ARR and an 80%-90% ARR growth versus 2025.
- The acquisition is expected to generate $7 million in revenue synergies and $4 million in cost synergies, with Gleamer currently having a negative EBITDA of $4 million-$5 million on a run rate, and is projected to reach break-even by mid-2027.
7 days ago
RadNet Acquires AI Company Gleamer
RDNT
M&A
Guidance Update
New Projects/Investments
- RadNet announced the acquisition of Gleamer, a Paris-based AI company specializing in clinical AI solutions for radiology, in an all-cash transaction valued at up to EUR 230 million ($270 million USD).
- Gleamer, which has demonstrated 90% annual recurring revenue (ARR) growth over the last four years, is expected to contribute $30 million in ARR for 2026.
- The combined entity (DeepHealth and Gleamer) is projected to achieve $135 million-$145 million in revenue for 2026, with $120 million-$140 million in ARR and an 80%-90% ARR growth versus 2025.
- RadNet anticipates realizing over $7 million in revenue synergies and over $4 million in cost synergies, with cost synergies expected to help Gleamer reach break-even by mid-2027. The acquisition strategically completes RadNet's multimodality AI capabilities, particularly in X-ray imaging.
7 days ago
RadNet's DeepHealth Acquires AI Company Gleamer
RDNT
M&A
New Projects/Investments
Revenue Acceleration/Inflection
- RadNet's DeepHealth division announced the acquisition of Gleamer, an AI-enabled health informatics company, for an all-cash transaction of up to EUR 230 million ($270 million).
- The acquisition significantly expands DeepHealth's clinical AI portfolio, increasing the combined entity's regulatory clearances to 26 FDA cleared and 22 CE marked devices and over 75 indications, particularly strengthening X-ray capabilities.
- Gleamer is projected to contribute $30 million in annual recurring revenue (ARR) for 2026 and has demonstrated 90% ARR growth over the last four years.
- The combined DeepHealth and Gleamer entity is expected to achieve $135 million-$145 million in revenue for 2026, with $120 million-$140 million in ARR and an 80%-90% ARR growth versus 2025.
- The acquisition anticipates over $7 million in revenue synergies and over $4 million in cost synergies, with cost synergies expected to be captured earlier, aiming for Gleamer to reach break-even by mid-2027.
7 days ago
RadNet Provides 2026 Guidance and Discusses Strategic Initiatives
RDNT
Guidance Update
M&A
New Projects/Investments
- RadNet provided 2026 guidance, anticipating 16% to 18% revenue growth for its imaging center side and around 50% growth for its digital health side, with imaging center EBITDA expected to grow faster than revenue.
- The company expects a $7 million to $9 million impact on Q1 2026 from bad weather in the Mid-Atlantic and Northeast regions, compared to a $15 million EBITDA impact from weather and fires in the prior year.
- RadNet acquired Radiology Regional for $65 million, a practice generating over $100 million in revenue from 13 centers in Southwest Florida, which is expected to contribute mid to high single digits in EBITDA.
- The company also acquired Gleamer, an AI-assisted X-ray reading technology, and anticipates four FDA approvals in the next couple of quarters for AI products related to lung, prostate MRI, breast arterial calcification, and breast ultrasound.
- Advanced imaging modalities (MRI, CT, PET CT) represented 28.6% of volume in Q4, a 178 basis point increase year-over-year, and account for over 60% of total revenue.
Mar 3, 2026, 7:15 PM
RadNet Provides 2026 Guidance and Strategic Updates at Raymond James Conference
RDNT
Guidance Update
M&A
New Projects/Investments
- RadNet anticipates 16% to 18% revenue growth for its imaging centers and around 50% revenue growth for its digital health segment in 2026, with imaging center EBITDA expected to grow faster than revenue.
- The company expects mid to high single-digit EBITDA contribution from recent imaging center acquisitions, including a major acquisition in Southwest Florida for $65 million which generates over $100 million in revenue.
- Key growth drivers include mid-single digit same-store procedure volume growth for MRI and CT, double-digit growth for PET CT, and a 178 basis point increase in advanced imaging as a percentage of total volume in Q4.
- Headwinds for 2026 include an estimated $30 million impact from 4% same-center labor cost increases and a projected $7 million-$9 million impact in Q1 from winter weather conditions.
- RadNet is integrating AI solutions, including the recent acquisition of Gleamer for X-ray AI-assisted reads, and expects four FDA approvals for AI products within the next couple of quarters, including a lung cancer detection solution.
Mar 3, 2026, 7:15 PM
RadNet Provides 2026 Guidance and Strategic Updates
RDNT
Guidance Update
M&A
New Projects/Investments
- RadNet projects 16% to 18% revenue growth for its imaging centers and around 50% growth for its digital health segment in 2026, with imaging center EBITDA expected to grow faster than revenue.
- Growth is anticipated from mid-single digit same-center organic growth in advanced imaging modalities, contributions from two imaging center acquisitions (including Radiology Regional), new de novo centers, and a $4 million-$5 million Medicare reimbursement benefit.
- The company expects headwinds from approximately 4% same-center labor cost increases (around $30 million) and an estimated $7 million-$9 million impact from Q1 2026 weather conditions.
- RadNet is advancing its digital health strategy, including the acquisition of Gleamer for AI-assisted X-ray reads (X-ray is 23.5% of volume), and anticipates four FDA approvals for AI products in the coming quarters, alongside efforts to achieve potential 10% savings from its $60 million human call center costs through automation.
Mar 3, 2026, 7:15 PM
RadNet's DeepHealth Acquires Gleamer
RDNT
M&A
New Projects/Investments
Revenue Acceleration/Inflection
- RadNet's DeepHealth has acquired Gleamer, a Paris-based startup, positioning the combined entity as the largest radiology AI provider worldwide.
- The combined entity is guided to deliver $135 million-$145 million in revenue and $120 million-$140 million in Annual Recurring Revenue (ARR) for 2026, implying an 80%-90% ARR growth.
- This acquisition expands the clinically validated portfolio to over 75 indications and is expected to generate $7 million-plus in revenue run rate increase from commercial synergies and $2 million in direct cost savings.
- The integration significantly enhances DeepHealth's capabilities and workforce, bringing Gleamer's 131 employees, including over 70 in R&D, to accelerate product development and market reach.
Mar 2, 2026, 6:00 PM
Quarterly earnings call transcripts for RadNet.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more